FDA Permits Marketing Of First Test For Norovirus Outbreaks
The U.S. Food and Drug Administration has allowed marketing of the first test for the preliminary identification of norovirus.
The Ridascreen Norovirus 3rd Generation EIA assay is for use when a number of people have simultaneously contracted gastroenteritis and there is a clear avenue for virus transmission, such as a shared location or food, like a [...]








